Abstract
Neurotoxic products produced during tryptophan metabolism via the kynurenine pathway could be involved in schizophrenia pathogenesis. It has been shown that kynurenine-3-monooxygenase (KMO) is indirectly involved in these products’ formation. KMO polymorphic loci rs2275163 (C/T) and rs1053230 (A/G) were examined in 187 schizophrenia patients and 229 healthy subjects. A genetic combination of allele T and genotype GG was observed more often in a patient group compared with healthy controls (p = 0.003, OR 2.0 (95% CI 1.2–2.9)). In the latter group, this combination was associated with schizophrenia endophenotype (p = 0.04), which manifested in a higher expression of schizotypal personality traits assessed using the MMPI test.
Similar content being viewed by others
References
Erhardt, S., Schwieler, L., Nilsson, L., et al., The kynurenic acid hypothesis of schizophrenia, Physiol. Behav., 2007, vol. 92, nos. 1–2, pp. 203–209.
Muller, N. and Schwarz, M., Schizophrenia as an inflammation-mediated disbalance of glutamatergic neurotransmission, Neurotox. Res., 2006, vol. 10, no. 2, pp. 131–148.
Schwarcz, R., Rassoulpour, A., Wu, H.Q., et al., Increased cortical kynurenate content in schizophrenia, Biol. Psychiatry, 2001, vol. 50, no. 7, pp. 521–530.
Wonodi, I. and Schwarcz, R., Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in schizophrenia, Schizophr. Bull., 2010, vol. 36, no. 2, pp. 211–218.
Sathyasaikumar, K.V., Stachowski, E.K., Wonodi, I., et al., Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia, Schizophr. Bull., 2011, vol. 37, no. 6, pp. 1147–1156.
Hamshere, M.L., Bennett, P., Williams, N., et al., Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to disc1, and suggestive evidence at 22q11 and 19p13, Arch. Gen. Psychiatry, 2005, vol. 62, no. 10, pp. 1081–1088.
Aoyama, N., Takahashi, N., Saito, S., et al., Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population, Genes Brain Behav., 2006, vol. 5, no. 4, pp. 364–368.
Holtze, M., Saetre, P., Erhardt, S., et al., Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: an association study, Schizophr. Res., 2011, vol. 127, nos. 1–3, pp. 270–272.
Holtze, M., Saetre, P., Engberg, G., et al., Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls, J. Psychiatry Neurosci., 2012, vol. 37, vol. 1, pp. 53–57.
Wonodi, I., Stine, O.C., Sathyasaikumar, K.V., et al., Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes, Arch. Gen. Psychiatry, 2011, vol. 68, no. 7, pp. 665–764.
Keshavan, M., Montrose, D.M., Rajarethinam, R., et al., Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments, Schizophr. Res., 2008, vol. 103, nos. 1–3, pp. 114–120.
Lien, Y.J., Tsuang, H.C., Chiang, A., et al., The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia, Am. J. Med. Genet., Part B, 2010, vol. 153B, pp. 1–9.
Tarbox, S.I., Almasy, L., Gur, R.E., et al., The nature of schizotypy among multigenerational multiplex schizophrenia families, J. Abnorm. Psychol., 2012, vol. 121, no. 2, pp. 396–406.
Lavebratt, C., Olsson, S., Backlund, L., The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression, Mol. Psychiatry, 2013. doi 10.1038/mp.2013.11
Craddock, N., O’Donovan, M.C., Owen, M.J., Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or “schizoaffective”) psychoses, Schizophr. Bull., 2009, vol. 35, no. 3, pp. 482–490.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.E. Golimbet, T.V. Lezheiko, M.V. Alfimova, L.I. Abramova, N.V. Kondrat’ev, 2014, published in Genetika, 2014, Vol. 50, No. 6, pp. 724–728.
Rights and permissions
About this article
Cite this article
Golimbet, V.E., Lezheiko, T.V., Alfimova, M.V. et al. Association of kynurenine-3-monooxygenase gene with schizophrenia. Russ J Genet 50, 634–637 (2014). https://doi.org/10.1134/S1022795414060039
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795414060039